k

Saturday, January 30, 2010

Hot 10 Stocks For 2010

Hot 10 Stocks for 2010 for the Recovery from America's Leading Advisors marks the eleventh edition of NewsletterAdvisors.com's complimentary signature publica-tion. Each and every edition brings the best in investment ideas from the brightest minds in investing today to individual investors just like you.

Since NewsletterAdvisors.com was launched in November 2005, tens of thousands of individual investors from all over the world have visited the site and downloaded copies of our reports. We thank all of those who have downloaded previous editions of the report for their overwhelmingly positive feedback. As you evaluate your portfolio into 2009 we hope that you will turn to this special report from NewsletterAdvisors.com for ideas and inspiration. If this is your first time requesting a free report from us, you can also look forward to receiving 24/7 Investor's Daily Profit email newsletter, Featuring timely stock recommendations and analysis on the news that's really moving the market, plus interviews with investment experts, including contributors to NewsletterAdvisors.com special reports, Daily Profit is your indispensable guide to navigating a challenging market.

Enjoy this special report and the outstanding investment ideas from our hand selected investment experts. We also encourage you to consider some of the special offers from the contributors to this special report, including free trial memberships, subscription discounts, and additional bonus reports. Please see page 13 of this report for complete details, or click here to take advantage of these free offers today!

Thanks again for turning to NewsletterAdvisors.com, your trusted source for investment information.

Hot 10 Stocks for 2010 No.1 Atlas Pipeline Partners
by Addison Wiggin

I've been involved in investing and financial markets for the past 15 years. In that time, I've met every kind of investor... and heard about every kind of investing strategy and stock opportunity you can imagine. Here at Agora Financial, we scour the globe looking for hidden investment opportunities often over looked by Wall Street. Capital &Crisis editor Chris Mayer uncovers these opportunities and delivers them to you. Chris is called by some "the best financial journalist you've never heard of ..."

And on behalf of Chris Mayer... I'll gladly put every minute of my hard work and reputation building on theline. His Capital & Crisis subscribers have benefited greatly from his unique recommendations. His globetrotting letter knows no bounds and goes wherever profits can be found. Over to Chris… Finding the Great Investments He's BeenSearching for His Whole Career I'm going to show you how you can start collecting a 20%-plus yield -- on one overlooked energy stock --right away. Besides these plumpdividends, you'll get a good shot at tripling your money. And there's good reason to believe you could make nine times your money -- if Wall Street wakes up and smells hard assets, and pays exactly what they're worth.

The market isn't rewarding Exxon, Chevron or even Gazprom. And now is not the time to start taking risks on wildcat energy explorers. Right now, I'm looking at a stock that's trading under $6. And today, it's showing signs of a climb -- so I wouldn't wait on this opportunity. Just let me give you the bare bones of its business and a nod from a very smart billionaire investor who knows tough markets.

The company's secret is that it doesn't drill for a drop of oil and it doesn't frack a single foot of shale gas. What it does is keep companies who do at its mercy.
Atlas Pipeline Partners (APL:nyse) owns 1,600 miles of pipeline connected to nearly 6,000 wells and is adding over 800 new wells per year in Appalachia. It also operates a growing interstate pipeline system in the Fayetteville Shale. Plus, it has a great deal with one of the most active drillers in America: Atlas Energy. Every well that Atlas Energy drills has to be connected to Atlas Pipeline's system. These are low-risk assets. Now let's talk dividend. Since 2000, APL's average dividend increase clocked in at 7 cents a year. A plump year offered a 107% increase. While it's true that 2008 was a tough year for natural gas, NGLs (APL's primary product) are up 50% from their December lows. Aside from price recovery, there's another catalyst for dividend growth. Given the prime location of its pipelines in Appalachia, you have every reason to expect an increased dividend payout down the road.

War horse Leon Cooperman, shares my interest in APL. He is one of the great living investors. At a recent Manhattan value investors' conference, Cooperman confessed, "This is the most difficult environment I've lived through. And I've been doing this for 41 years."  But when he got to talking about getting 20%-plus on your money with APL, he had this to say: "At my age, it's better than sex, but that's just me."

Why does he think Atlas is on sale? Thank collapsing hedge funds the most. These guys have been forced to sell even their best positions to cover losses in other areas. Cooperman thinks this stock is worth $46 easily. My original estimate was $48. That's nine times what it trades at today. So why not consider a stock trading at so steep a discount to book?

Don't forget the great yield -- that's poised to increase. Even if that dividend stays right where it was last quarter, you could still make back today's investment in under four years -- just through the dividend alone.
Recommendation: Buy Atlas Pipeline Partners (APL: NYSE).

 

Hot 10 Stocks for 2010 No.2 U.S. Cellular 8.75% Senior Notes due 11/1/2032 (NYSE: UZG, $20.25)
by Nilus Mattive

Famed investor Warren Buffett made a telling remark on the kind of returns he hopes to achieve in today's tough markets: "We would be very happy if we earned +10%, pre-tax," he told shareholders at Berkshire Hathaway's (NYSE: BRK-B) annual meeting last May. Co-Chairman Charlie Munger quickly concurred, "You can take what Warren said to the bank... and I suggest you adopt the same attitude."

Well, my recommended security for this market bests Warren Buffett's benchmark. It offers secure yields of better than 16%. And we do mean secure -- as in legal obligation.Although this security trades like a stock every day on the New York Stock Exchange, it's actually a bond, not a stock. That means your quarterly interest payments have top claim on the company's assets, ahead of any common or preferred share dividends if the company runs into trouble. That kind of security is comforting in today's turbulent times, but it's hardly necessary for America's sixth biggest wireless firm. In fact, credit rating agency Standard & Poor's is so confident in this firm's financial position, it just upgraded the company's credit quality to investment grade "with positive out look," meaning the rating could be raised in one to three years.

The upgrade and positive outlook mean that any such bonds the company may issue in the future will most likely offer a lower interest rate than this high-yielding security. That's because today's featured security was issued in 2002, when the company was considered higher risk and needed to offer a higher rate in return.
Consider, too, that this security is now trading at around a -19% discount from its $25 par value. It matures in 24 years and can be called at any time. Either way, sooner or later you will be getting back $25 per share plus any unpaid interest. Meanwhile, you'll be paid amply to wait. If this all sounds too good to be true, read on and decide for yourself...

Snapshot: These exchange-traded notes were issued in 2002 by regional wireless operator U.S. Cellular (NYSE: USM). The company is the sixth-largest wireless carrier in the country by number of customers. Its wireless networks serve 6.2 million customers, for an estimated 3% share of the U.S. wireless market. Headquartered in Chicago, the telecom carrier focuses on smaller regional markets mainly in the Midwest, including Illinois, Indiana, Iowa, and Wisconsin.

Key Statistics:
Security Type: Exchange-Traded Debt
Annual Dividend: $2.1875
Dividend Yield: 10.8%
Frequency: Quarterly
Credit Rating: Baa3/BBB

Wireless services account for about 93% of revenues, while equipment sales contribute the balance. Roaming revenues from other wireless carriers using USM's networks provide a 7% chunk of the company's wireless service revenue. U.S. Cellular is a subsidiary of rural fixed-line phone operator Telephone & Data Systems (NYSE: TDS), which owns 80.8% of the company.

Performance: U.S. Cellular has seen earnings grow an average of +50.2% a year over the past three years through December 31, 2007. U.S. Cellular has a strong balance sheet, which is supported by funding from parent company TDS. Its debt-to-EBITDA (earnings before interest, taxes, depreciation, and amortization) ratio, a measure of leverage, is less than 1.0. Meanwhile, debt is only around 20% of total capitalization. Both those measures are well below its regional wireless peers. Rival Leap Wireless (Nasdaq: LEAP), for example, carries a debt-to-EBITDA ratio of 6.4 times, and debt is 60% of total capitalization.

 

Hot 10 Stocks for 2010 No.3 Strike Gold with SPDR Gold Shares (GLD)
by Ian Wyatt

If the gains gold has made are any indicator of profits to come, I think  SPDR Gold Shares (NYSE:GLD) is the golden ticket investors need to expose their portfolio to the safety and profits of the precious yellow metal.

Gold has been one of the best performing investments in a down market, and was one of the only investments to post gains in 2008, proving to be an excellent safe haven. Like U.S. Treasuries, the price of gold has rallied as investors fled equities and bonds, and sought safe investments. SPDR Gold Shares is an ETF that trades at one-tenth the price of an ounce of gold, and tracks the price movement of the commodity. The metal has most notably been on the rise, jumping 31% to $923 an ounce from the recent Nov. 13 low of $700 an ounce. As I mentioned in my weekly letter on Monday, I had been considering buying the Market Vectors Gold Miners Index (NYSE:GDX). However, this higher-risk, higher-reward investment has soared an astounding 74% from a recent Oct. 27 low, making it much riskier than GLD.

Through SPDR Gold Shares, I intend to take a cautious approach to gaining exposure to gold, given the big gains that the ETF has already experienced in the last few months. I plan to start with a small position of $2,000, and may add to the position in the future. I don't intend to have more than 5% of my portfolio invested in this position at any time.

For any Goldfingers out there, investing in SPDR Gold Shares is much like buying gold bars or coins, minus the headache of having to hold them in a safe or hide them under your bed. Using the fund, you have the added flexibility of being able to buy or sell at any time. The fund is backed by physical gold reserves, giving investors the security of buying the real commodity.

Many commodity prices dropped in 2008, including gold, which fell briefly in October and November of 2008. Don't let this brief decline fool you though - this is a long-term bull market for commodities, and gold will continue to perform well. As investors ditch low-yield U.S. Treasuries and seek other inflation-protected investments that can provide safety, gold appears to be the perfect investment.

The reckless monetary policy of the U.S. Federal Reserve will have its day of reckoning in the future, and investors who are long-gold and have investments that aren't tied to the greenback will be smiling in the years to come.

Let's face it: once the economy picks up, deflation will change into inflation. And hyper-inflation isn't far off, as a result of a U.S. government that continues to spend aggressively and issue more curren cy in a thus far failed attempt to jumpstart the U.S. economy. This anti-inflation investment allows investors in the United States to diversify out of the dollar and own an asset backed by a physical commodity that is likely to see greater demand with limited additional supply coming on line in the coming years.I plan to begin with a small position, which I may add to if I see a breakout in the price of gold. I'll also look to add to my position if prices consolidate, which I think is quite possible given the recent jump in price.

 

Hot 10 Stocks for 2010 No.4 How One Tiny Drug Developer Could Take Down The Industry Leaders
by Greg Guenthner

Grab Your Share of a $31 Billion Market In 2007, the global pharmaceutical pain relief market was worth approximately $31 billion. In the U.S., two-thirds of the dollar volume of the prescription pain medication market is for drugs used to treat chronic pain, with the remainder going toward drugs used for acute pain.
Javelin Pharmaceuticals Inc. (JAV: AMEX) designs products to fulfill unmet and underserved medical needs in the pain-management niche. The company is particularly focused on breakthrough cancer, post-operative, back, orthopedic injury and burn pains. Despite the advances in medicine, the company insists treatments for these types of pain continue to be an underserved medical need. That's where Javelin's lucrative new contract comes into play…

The company penned an agreement in January worth up to $71 million that includes double-digit royalties on future sales of its new pain drug, Dyloject. Javelin will receive roughly $12 million in upfront cash payments from European pharmaceutical developer Therabel for the commercialization rights for Dyloject, the flagship product in Javelin's current pipeline. Dyloject is an injectable form of diclofenac, which is a prescription anti-inflammatory drug often prescribed to treat postoperative pain.

Dyloject is undergoing Phase 3 clinical development in the United States - the drug is already available in the United Kingdom. During its pivotal U.K. registration trial, Dyloject's efficacy and safety were shown to be significantly superior to standard intravenous treatments currently marketed in the U.K.

A Faster, Better Treatment
The competition for Dyloject requires dilution and slow infusion into the patient. But Dyloject comes ready to use for immediate IV administration. Anti-inflammatory drugs such as Dyloject, along with opioids like morphine, are often used post-operatively. They help reduce opioid doses by as much as 50%, thereby decreasing morphine-related side effects on the patient.

Dyloject's most significant U.S. competitor in the injectable antiinflammatory category is ketorolac tromethamine. In January 2006, Javelin announced the results of a Phase 2b U.S. study in which Dyloject showed superior onset of action compared with ketorolac five minutes after intravenous injection.

Bottom line: This drug does what it is supposed to do. And it does it better than all of the leading competitors. That's the ringing endorseent for Dyloject…especially since it's awaiting approval in the U.S. U.K. Sales and European Agreement Are Signs of Things to Come Dyloject is already on the market in the United Kingdom, and sales have been growing at an impressive pace. The drug is now on the formularies of 73 hospitals in the U.K., 58 of which were considered gold accounts and 15 silver accounts. In the first nine months of its availability, Dyloject was accepted at 40% of their targeted accounts. The drug has been accepted at 95% of the institutions to which it's been presented. This, Driscoll believes, shows that Dyloject has value to clinicians. It will prove valuable to shareholders, too…

Since Dyloject was introduced to the market, sales of the drug have doubled each quarter. Although that may be a small sample size, it shows the growth potential of the product once it is introduced into a wider market.Javelin is on schedule to complete its studies on Dyloject and submit applications in late 2009 for approval in the U.S. and European markets. The partnership with Therabel helps Javelin accelerate this process.Javelin's a Bargain at Current Prices Javelin has put itself in a fantastic position to succeed. The company currently has $34.6 million in cash and equivalents and no long-term debt whatsoever. Its burn rate during the first three quarters of 2008 was $8.6 million. With $12 million in upfront cash from Therabel, the company is well positioned to wait out approval in the U.S. Javelin feels that the self-medication segment is an area of possible growth. It generally takes 15-20 minutes and sometimes as long as 40 minutes for commercially available oral pain medications to provide any meaningful relief. Javelin says that all three of its product candidates appear to work faster than the oral formulations of currently available prescription pain products. Dyloject has shown to relieve pain in as little as five minutes, a mark that has not been achieved by current injectable anti-inflammatory drugs.

Recommendation: Buy Javelin Pharmaceuticals Inc. (JAV: AMEX).

 

Hot 10 Stocks for 2010 No.5 Abercrombie & Fitch
by Bernie Schaeffer

At Schaeffer's Investment Research, we employ a 3-tiered analysis approach known as Expectational Analysis® (EA) that was created more than 2 decades ago. EA utilizes traditional methods of fundamental and technical analysis and combines these with a third, crucial look at investor sentiment. It is this third layer of analysis that provides a critical edge in selecting stock and option plays. Both anecdotal and quantifiable measures of investor sentiment provide a window into how the investing crowd perceives reality. These perceptions serve as powerful contrarian indicators, as the crowd tends to move as a herd and is, to paraphrase the venerable contrarian Humphrey Neill, "right during the trend but wrong at both ends."  A look into the psyche of the collective investing masses, while also taking into account important technical and fundamental variables, can offer a reliable recipe for trading success.

The latest opportunity found by the EA methodology is  Abercrombie & Fitch (ANF). According to Hoover's, Abercrombie & Fitch (A&F) sells upscale men's, women's, and kids' casual clothes and accessories. The firm has 1,000-plus stores in North America (mostly in malls) and also sells via its catalog and online. It targets college students, and has come under fire for some of its ad campaigns, as well as for some of its short-run products. The company also runs a fast-growing chain of some 450 teen stores called Hollister Co., and a chain targeted at boys and girls ages 7 to 14 called abercrombie. RUEHL, a Greenwich Village-inspired concept for the post-college set, debuted in 2004.

In early February, earnings rolled in from the trendy retailer, surpassing the consensus estimate. For the fourth quarter, the company posted a profit of $68.4 million, or 78 cents per share, compared to its year-ago profit of $216.8 million, or $2.40 per share. Excluding impairment charges and costs tied to a new employment agreement with its CEO, the retailer boasted a profit of $1.10 per share, beating the Street estimate for a profit of $1.01. Sales fell 19% to $998 million, said the company. ANF stated that it would not issue an earnings forecast for fiscal 2009, citing a tough year ahead. The company said it expects a difficult selling environment to continue.

Abercrombie forecasts capital expenditures of $165 million to $175 million in fiscal 2009, a major portion of which is tied to new stores and remodeling.
Technically speaking, the security gapped sharply higher on the earnings report, gaining more than 10% amid broad market weakness.What's more, this significant bullish gap has placed the equity above resistance at its 80-day moving average. This short-term trendline had capped the shares' recent rally attempts.

As followers of the EA method, we ideally like to see solid price action persist against a backdrop of skepticism, as this implies that there could be additional money waiting on the sidelines that hasn't yet been committed to the bullish cause. It seems as though there is plenty of room on the bullish ANF bandwagon. Options players have leveled some heavy bearish bets against the stock in an attempt to call a top to its uptrend. The Schaeffer's put/call open interest ratio for ANF stands at 1.28, as put open interest outweighs call open interest among near-term options. This reading is also higher than two-thirds of those taken during the past year, indicating extreme skepticism among short-term options speculators.Meanwhile, Wall Street has yet to fully jump on this outperforming security. According to the latest data from Zacks, 14 of the 19 analysts following ANF rate it a "hold" or worse. Any upgrades from these remaining holdouts could help to propel the shares higher during the long term.

Overall, this combination of pessimistic sentiment against the stock's backdrop of improving earnings and strong technicals has bullish implications from a contrarian perspective. As investors unwind their bearish bets and jump on the stock's bandwagon, they will help to push the security even higher.

 

Hot 10 Stocks for 2010 No.6 Redefining Pharmacy Benefit Managment
by Ian Wyatt

The way I see it, even through current market malaise, SXC Health Solutions (Nasdaq:SXCI) is standing firm with its two corporate feet firmly planted in two complementary arenas: it's providing pharmacy benefits management services and developing the technology engine needed to keep costs under control.
Bringing down health-care costs remains a hot-button issue, as the baby boomers reach retirement age, Medicaid and Medicare grow, and drug costs continue to rise.

SXC Health, formerly known as Systems Xcellence, is a niche player in the benefits marketplace. Headquartered outside Chicago, SXC Health is a provider of health-care information technology solutions and services to providers, payers and other participants in the pharmaceutical supply chain in North America.

SXC Health is redefining pharmacy benefit management (PBM) by providing a broad range of pharmacy spend management solutions and information technology capabilities. The company is a leader in delivering an innovative mix of market expertise, information technology, clinical capability, scale of operations, mail order and specialty pharmacy offerings to a wide variety of healthcare payor organizations including health plans, Medicare, managed and fee-for-service state Medicaid plans, long-term care facilities, unions, third-party administrators and self-insured employers. In essence, the company's services allow customers to make good decisions and save money.

SXC Health's informedRx business sells management services mostly to government and universities, while its Healthcare IT Group develops the technology behind the services and provides a revenue stream via software licensing.

SXC's recent acquisition of National Medical Health Card Systems expanded its informedRx services, which is a broad, flexible suite of à la carte PBM services, which provide flexible and cost-effective alternative to traditional PBM offerings. The acquisition is an essential step in SXC Health's strategic evolution toward being a leader in pharmacy spend management, and gives the company's customers the chance to pick and choose what services are right for them. SXC Health is the only company in the PBM space to offer its clients such a broad portfolio of solutions SXC Health's technology touches close to 1 in every 4 of the estimated 3.5 billion prescriptions written in the United States annually - a plus considering that the health-care sector and health-care IT industry will outperform the market for the next few years.

The company also stands to benefit from demographic and political trends, in that the population is aging and pharmaceutical companies will need SXC's products and services. Also, the new administration has vowed to digitize the health-care system. Both of these trends will positively influence SXC Health's earnings.
In the quarter ended Sept. 30, 2008 earnings were $3.5 million, or $0.15 per share, up from $2.7 million, or $0.12 a year ago. Revenue increased to $318.1 million from $22.2 million. SXC increased full-year EPS guidance to $0.54 to $0.58 a share, from its previous estimate of $0.41 to $0.50. Additionally the company narrowed revenue estimates to $840 to $855 million, from $825 million to $875 million. We forecast the company will earn $0.59 EPS in 2008 and grow EPS 50% in 2009 to $0.88. We expect revenues will be $854 million this year and increase 52% to $1.3 billion next year. The company has made brilliant acquisitions in recent years, which have made it one of the primary players in pharmacy spend management services and information technology solutions.

The company was recently trading at 32 times current year EPS and 22 times forward EPS. These are high multiples in the current environment, but SXCI shares are worth every penny. In fact, shares are worth more. We estimate fair value to be $28 based on EPS and revenue growth projections.

 

Hot 10 Stocks for 2010 No.7 Power Lines and Trees: A Dynamic Duo for Income And Growth
By Justice Litle

They may not be sexy, but it's hard to go wrong with trees and power lines. In fact, we'll be using that unlikely duo to execute this "perfect inflation hedge."
Brookfield Infrastructure Partners (BIP:NYSE). BIP is a limited partnership (though its cash flows are not subject to the same tax treatment as MLPs, or Master Limited Partnerships).

Brookfield Infrastructure Partners (BIP) is a spin-off from a much larger mother ship, Brookfield Asset Management (BAM:NYSE).While little BIP is small and scrappy at $316 million, mother BAM boasts a far larger market cap of $9.5 billion.As a publicly traded partnership, 50% of BIP is owned by investors like you and me. Forty percent is owned by BAM, the parent, and the last 10% is owned by Brookfield directors and management.

BIP was spun off from the BAM mother ship with the intent of being a "pure infrastructure play." The far larger BAM has all sorts of assets on its balance sheet; through the creation of a stand-alone entity, BIP offers a way to pick up direct infrastructure exposure.BIP's primary assets are electricity transmission lines and timber, and they are distributed across North and South America. On the electricity side, BIP owns roughly 5,500 miles worth of transmission lines (power lines) in Chile and Canada (Northern Ontario). Additional power lines in Brazil were sold at a considerable profit in the third quarter of 2008.

BIP's transmission lines are part of a regulated monopoly, which means no competitor can muscle in. As of March 2008, these assets had a recorded book value of $330 million -- more than the value of BIP's current market cap. Using the Brazilian asset sale as a benchmark -- in which BIP fetched a 40% gain over book price -- its likely current holdings have a far, far higher value than the old numbers reflect.

A Toll Road for Electrons
Power lines are a great business. Just as you have to drive to work each day (unless you're retired or work from home), the electricity has to move from the power plant to your house (or the office building, the factory and so on).

Here's why you want to own power lines:
They require very little maintenance and upkeep, so most of the cash flow goes right into the owner's pocket.
Because people and businesses are steady in their use of electricity, those cash flows are very stable.
As inflation rises, steady price increases can be pushed through as part of the contract.

Additionally, BIP will have the chance to build out its electricity transmission networks at attractive rates of return over time. The only thing better than a strong, stable, cash-flow-producing business is a business that can expand on the same great terms. As emerging markets resume their upward trends, electricity use will go up too... and this can only be good news for BIP.

An Infinite Resource
The other thing BIP owns is timber -- more than 1.2 million acres in Oregon,Washington state, and coastal British Columbia. The nice thing about timberland is that, when managed properly, it's an infinite resource. Unlike metals or fossil fuels -- which eventually run out and leave a site in decline -- trees can grow back.
As with electricity, BIP's parent company (and 40% owner) offers four decades of experience owning and operating timberlands. This gives BIP an edge in key areas like harvest planning and managing the product mix.

BIP's acreage is concentrated in premium timbers like Douglas fir and hemlock. In addition, the close proximity to the coast gives BIP an edge on the export side of the business.

Timberland tends to rise in value over time because, unlike the currency spit out of a printing press, they just aren't making any more of it. Timber's uses are many and varied for the global economy, and, like power lines, timber has the advantage of being a high-margin, low-upkeep business.

When prices are high, BIP can cut more timber. When prices are low, they can cut less (saving costs) and let the acreage value appreciate. The timber itself is a renewable resource, and BIP has the ability to book capital gains through the occasional sale of choice parcels for land redevelopment.

An Exceptional Value
Investors are coming back to their senses, snapping up assets that got insanely cheap. BIP's parent could well be buying back shares too, figuring it's crazy to leave them out on the market at such a tempting price. Back in March of 2008, management gave an estimate of BIP's book value (the value of the underlying transmission and timber assets) at $24 per share. I think that is not only a reasonable estimate; it is more than likely a conservative estimate. BIP could easily be worth $25 to $30 per share.

As we prepare for a central-bank-induced inflation deluge, stable, cashflow producing infrastructure assets will only increase in value. Power lines and trees will never go out of style... and the stream of income collected from those assets will only keep ticking up year after year. Buy Brookfield Infrastructure Partners (BIP:NYSE) at $18 per share or better.

 

Hot 10 Stocks for 2010 No.8 Big Profits from Downsizing
by Stephen Rawls

All Americans are changing their spending habits as the economic recession hits home. We're adjusting to the idea of driving the car an extra year or more, to buying clothes at Sears instead of Joseph A Banks, that sort of thing. And while our change in spending habits hurts some, it helps others. As investors, we need to focus on those companies well positioned to profit from these changes. Those companies well positioned to profit from the fundamental changes in the American lifestyle.
One of the major changes that we're seeing now is a turn by the American consumer to private label brand foods to feed their family. As a result, one of the big beneficiaries of this move is American Italian Pasta Company (AIPC), the nation's largest manufacturer of dry pasta. Sales are booming. And so is the stock.

What makes American Italian Pasts so interesting is that it's booming because of several trends. The first is the aforementioned transition to private label foods. A second favorable trend is that consumers are moving away from a meat and potatoes diet to something less expensive, like pasta. And, finally, the low-carb "Atkins diet" fad is now history. Even more amazing in the recession of 2009, American Italian Pasta has actually been able to raise their prices while sales increased! Sales of pasta products in the United States rose 5% last year to $6.4 billion. During that time, American Italian was able to raise prices faster than their costs increased.
For the first quarter 2009, American Italian Pasta earned a whopping $1.23 EPS, up from 2008's first quarter EPS of 43 cents. Retail revenue for the quarter rose 56% to $136.1 million, while cost of goods sold rose only 40%. Overall volume for the company was up some 13%.

From a technical standpoint, American Italian Pasta seems to defy the overall market, making new highs as recently as February 25th. The company is a newly listed issue on the NASDAQ, beginning trading there on November 14, 2008. The company is trading above its 50-day moving average and gapped higher on February 12th after releasing its first-quarter earnings. Since then, the stock hasn't looked back.

With no upside resistance to speak of, the critical technical support level comes in the gap between $27.00 and $29.19. Given the strong earnings report on February 11th, I wouldn't expect the stock to violate this gap. Prospects for the company seem very strong and the company appears able to deliver on those prospects.

Pricing power is something almost unheard of in the economic climate of 2009. And that's one of the things that impresses me the most about American Italian Pasta - it has the ability to increase sales, while raising prices.

One other factor that hasn't yet been considered by most analysts, I believe, is that the cost of raw ingredients, which had been going up for most of 2008, are now in retreat.With higher prices already in effect, any fall in cost of goods sold will reflect directly in higher profitability for the company.

In summary, with American Italian Pasta, you have a company that's benefiting from multiple trends working in its favor. Fundamentally, the ability to raise prices and not affect sales is amazing. With more Americans "trading down" their eating habits, this trend to higher sales shows every indication of continuing. And with their raw ingredient prices now falling, the company will not have to raise prices in the near future to stimulate growth. Rather, the profits for the second quarter of 2009 will come from higher prices already in place, accompanied by falling ingredient prices.From where I sit, American Italian Pasta Company looks like a rare winner in 2009.

 

Hot 10 Stocks for 2010 No.9 Looking for Safe Stocks? Try Channeling Ben Graham
by John Reese

When I began conducting extensive research into the strategies used by some of history's greatest investors some 12 years ago, one thing quickly became apparent: Many of these Wall Street stars, including Peter Lynch, Warren Buffett, and Benjamin Graham, built their fortunes and reputations not by relying on some sort of investing "sixth sense", but instead by using approaches that were mostly or completely quantitative. They stuck to the numbers, never letting emotion influence their decisions.

That was great news to me. Because of my background in computer science and artificial intelligence, I was able to develop sophisticated but easy-to-use models based on these gurus' quantitative approaches.

Today, these models power the research and analysis on my web site, Validea.com, allowing everyday investors to take advantage of the strategies that some of history's most successful stock-pickers used. Since I started tracking them nearly six years ago, portfolios built using each of my eight original "Guru Strategies" have all significantly outperformed the market.

For some top picks in today's market, let's turn to my top-performing strategy -- one that, interestingly, is inspired by what is far and away the oldest of these methodologies, the approach of the late, great Benjamin Graham. Known as the "Father of Value Investing" -- and the mentor of Warren Buffett -- Graham detailed his strategy in his 1949 classic The Intelligent Investor. Six decades later, my conservative Graham-based model is up almost 70 percent since its July 2003 inception, while the S&P 500 has fallen more than 22 percent. Last year, while the market tumbled close to 40 percent, my Graham-based model sustained well less than half of that decline.

One stock my Graham model is particularly high on right now:
Ameron International Corporation (AMN), a California-based firm that makes water transmission lines, fiberglass-composite pipe for transporting oil, and infrastructure-related products like ready-mix concrete and lighting poles -- just the kind of company that could benefit from the federal stimulus package's infrastructure funding.

Having lived through both his own family's fall from financial grace (following his father's death when Benjamin was a young man), and, later, through the Great Depression, it's no surprise that Graham focused as much on preserving capital and limiting losses as he did on producing big gains. He liked stable, conservatively financed companies, not speculative gambles, and Ameron fits the bill. One example of why: its strong current ratio of 2.87. Graham used the current ratio (current assets/current liabilities) to get an idea of a company's liquidity (and the credit crisis has shown us all how important liquidity is).

Companies with current ratios of at least 2.0 were the type of financially secure, defensive, low-risk plays he liked, and Ameron makes the grade.Another way Graham targeted conservative firms was by making sure long-term debt was no greater than net current assets. Ameron has just $36 million in long-term debt and almost $300 million in net current assets, a great sign.

The other main part of Graham's approach was making sure a stock had what he termed a "margin of safety" -- that is, its price was low compared to his assessment of the intrinsic value of its underlying business. Stocks with high margins of safety have downside protection -- they're already selling at a discount compared to their real value, so even if problems occur and earning power declines a bit, the stock still might gain ground because it's so undervalued to begin with.
To find undervalued stocks, Graham looked at both the price/earnings ratio (the model I base on his approach requires the greater of the stock's current P/E or its three-year average P/E to be no greater than 15) and the price/book ratio (which, when multiplied by the P/E, should be no greater than 22). Ameron's P/E (using the higher three-year figure) is just 8.2, and its P/B is just 0.99, indicating that the stock is a great value.

In addition to Ameron, here are a couple more of myGraham model's current favorites:
Schnitzer Steel Industries (SCHN): Hammered when commodity prices began to tumble last summer, this Oregon-based firm has made a big rebound since late November, and my Graham model thinks it has a lot more room to grow. It has a current ratio of 3.2, just $106.1 million in long-term debt vs. $338.5 million in net current assets, and bargain-level P/E and P/B ratios of 5.8 and 1.01, respectively.

National Presto Industries (NPK): Talk about an eclectic group of business segments. This Wisconsin-based firm's housewares division makes small appliances and pressure cookers; its defense segment makes ammunition, fuses, and cartridge cases; and its absorbent products division makes adult incontinence products and baby diapers. Its fundamentals are exceptional -- current ratio of 5.23, P/E ratio of 14.5, P/B ratio of 1.49 -- and, the firm has no long-term debt.

 

Hot 10 Stocks for 2010 No.10 Hedged Investing with Hussman Strategic Growth
by Ian Wyatt

When I recently discovered the Hussman Strategic Growth fund, it was love at first sight. Hussman acts like a hedge fund, providing the fund managers much flexibility in the investment instruments and strategies utilized to capitalize on rapidly changing markets like those we are currently experiencing. Manager John Hussman's disciplined strategy has navigated the mutual fund toward calmer waters amid choppy market conditions, a testament to the fund's ability to achieve remarkable performance in down markets.

Although Hussman receives the advice of key personnel on the fund's board of trustees and at Hussman Econometrics, this mutual fund depends heavily on Hussman himself. He also invests all of his personal liquid assets (outside of cash and money market accounts) in his two funds, clearly aligning his personal interests with those of fund shareholders. Hussman Strategic Growth invests primarily in U.S. stocks with the objective of longterm capital appreciation. It currently has 116 long holdings that include the likes of Johnson & Johnson (NYSE:JNJ), Nike, Inc. (NYSE:NKE ), Amazon.com, Inc. (Nasdaq:AMZN), Coca-Cola (NYSE:KO) and Best Buy Co. (NYSE:BBY). Hussman goes long on individual positions, and can leverage using equity call options. Ninety percent of the fund's net assets are tied up in stocks while the remaining 10% is sitting in cash.

Hussman was down only 9% in 2008, a performance that was the envy of most fund managers, especially in light of the 37% drop in the S&P 500. In the previous bear markets of 2001 and 2002, the fund was up a whopping 14% in each of those years. Because the fund is so risk-averse, its short-term track record may limp in bullish environments, but its long term performance is where investors begin to see solid profits. Given the current state of the market, and the fact that my outlook calls for a range bound and volatile stock market in 2009, Hussman Strategic Growth fund is a solid place to have capital invested.

John Hussman develops a risk versus reward profile for the current market climate, identifying economic trends and valuing individual stocks based on their expected streams of cash flow. For much of the past decade, Hussman has considered most stocks overvalued and did not think they were providing enough reward given their high level of risk.To preserve capital, he hedged the portfolio against market risk by shorting indexes such as the S&P 100. As a result, the fund has been fairly uncorrelated to the whims of the market and has been shielded from the heavy losses many funds have faced.

Since its July 2000 inception, the fund's 8.9% annualized return has outpaced the S&P 500, which lost 4.4% annually over the same period.Performance in 2009 appears to be holding up, with year-to-date returns of 0.25% versus a loss of 8% for the S&P 500 index. Morningstar calls Hussman "one of the steadiest and cheapest options in the fledgling long-short category," and gives the fund a 3-star rating.

Hussman's claimed approach of "investing for long-term returns while managing risk" is in perfect alignment with my aggressiveapproach to conservative investing. I, too, aim to find opportunities for long-term capital appreciation, while limiting downside risk through portfolio diversification and aggressive risk management. The fund is currently taking a very conservative approach to equities, which makes sense given the performance last year. With the bleak prospects for global growth in 2009, this fund should perform well in horizontal or down markets, making it a nice fit within the equity portion of my Recovery Portfolio. Additionally, the fund's flexibility should allow it to perform nicely once stocks begin their recovery.

Friday, January 29, 2010

The New "Buy and Hold" 2010 Top Stocks

Where we are now is a matter of great debate: Are we in recovery? Or is the depression deepening?

No one knows for sure. Investors stumble around in the dark, bumping into data and knocking over lamps. It would be nice if someone would turn on the lights. But that's not how it works.

The best we can do is to try make out the shapes of the biggest pieces of furniture in the room. What else is out there? We don't know.

Broadly speaking, the period we are in is deflationary. It is a period of credit contraction (at least in the private sector), de-leveraging and depression. How can we be sure? Well, let's turn on the lights...

Take a look at this chart, for example. What it shows is not a 'jobless recovery.' It shows no recovery at all.

Job Losses in Recessions

This slump is worse than any since World War II because it is correcting an expansion that dates all the way back to 1945! Credit began increasing right after the war. It kept increasing until 2007. Then, in the private sector, it began going the other way.

That trend continues.

Total Revolving Credit Outstanding

It makes sense from a theoretical point of view, too. Every big credit expansion is followed by a big credit contraction. As credit expands, more and more mistakes are made. You can see how this works by looking at the mortgage industry. The first borrowers were solid. Subsequent borrowers were not-so-solid, but they were still generally reliable. The last borrowers - at the height of the frenzy in 2006 - often had no jobs, no income, and no plausible way of repaying their mortgages. Those mistakes are now being corrected.

Overall, credit is still expanding - thanks to the US federal government. But credit is contracting sharply in the private sector...where it counts most. Business lending is falling at a 16.6% rate... the steepest plunge since 1948 (when businesses stopped borrowing for war production). But government borrowing is more than making up for the shortfall in private borrowing. Overall, credit- market debt is up 5.5% in the seven quarters since the business cycle peak in December 2007.

Private sector credit down. Public sector credit up. What to make of it?

We can presume that eventually the government will run into the same wall the private sector hit in 2007-09. Looking through the history of economic crises, so well documented for us by Carmen Reinhart and Ken Rogoff, we see that crises in the private sector typically lead to crises in the public sector. As the private sector sobers up... the public sector goes on a spree. It won't be long before it, too, crashes and burns.

We can anticipate how this crash in public debt will come about. This passage, from a brief account of French financial history called The Undying Debt by Francois Velde, is a story of the past. It may also be a story from the future:

With the opening of hostilities [in WWI], the Bank of France suspended the link between francs and gold, and part of the war was financed with large issues of paper currency. When France's prime minister Poincare re-established the link in 1928, he could only do so at 20% of its pre- war parity.

In other words, the French got into a fix. They got out by defaulting on 80% of their obligations. The history of French financial management is not so different from that of any other nation. Time after time, France found itself a little short. And time after time, it defaulted...devalued...and reneged on its promises. Over nearly three centuries, a government debt equal to ten ounces of gold - with a present value of about �,850 - was reduced, says Velde, to �.20. That's about "enough to buy a café crème at the bistro on the way out from the Treasury."

(I don't know what bistro Velde is talking about. A café crème usually cost me twice as much!)

Returning to the image we led off with, investing is not just like trying to find your way through a room in the dark. It's like trying to find your way through a room in the dark...when the furniture is all moving! Trouble is, in the here and now there is so much furniture moving around, it is hard to make a move without tripping over something.

Under these conditions, I'm not sure we can come to any useful conclusions about how one price will move relative to the others. Which will go down most, the dollar or the euro? Will copper rise in dollars? Or fall against cotton? Will bond prices go up before they go down? We can't say.

But we can say that governments are very good at borrowing...and not so good at re-paying. So even if credit-contraction and deflation is the trend of the moment in US financial markets, government credit-creation is rapidly expanding...and that's inflationary.

That's why we are wary of government debt. We own no US Treasuries...or any other form of government obligation. Shorting US and European government bonds is probably a good speculative play.

Joel's Note: It is worth noting that Bill's last "Trade of the Decade" - buy gold/sell top stocks for 2010 - worked out rather well for those who listened. Stocks are, as we write, still in the red for the decade; and gold...well, you know how that's panned out. And with gold still over $1,000 LOWER than its all-time real high, there's still plenty of juice left to the upside. Nevertheless, our gold analyst has discovered a way you can own gold for as little as a penny per ounce...even if it rockets - as he fully expects it to - to $2,000 per ounce...and beyond.


And Bill continues with today's reckoning...

Now, here's some good news:

"US cattle herd falls to '58 levels."

That's good news because it means that maybe we'll be able to make some money from our scrawny 'sand fed' cows in Argentina. We bought the farm down there 4 years ago. Then, we had about 1,000 head. But we called in an expert - a tall, good-looking blond fellow named Juan Anderson. He told us to reduce the number of cows so they'd get enough to eat in our desert pastures. Now we're down to 600 cows. That leaves us with a crew of 7 gauchos with not enough work to do. So we're planting grapevines and walnut trees. Plus, we're going to build a masterpiece - a cottage of stone and adobe, with solar heating and a vaulted roof. But that project is for the future...stay tuned. In the meantime, we're trying to keep the gauchos busy...and hold down the losses.

Is this a good business model? Of course not. It's a hobby.

But there must be millions of hobby/businesses all over the world - marginal enterprises...struggling...barely making ends meet.

"Everything happens at the margin," said Keynes. A big, well-funded business, especially one with the government behind it, has the resources to survive a downturn. Even our little hobby business in Argentina can limp along for a few years - or until we go broke - whichever comes first. But there must be millions of other small entrepreneurs who are already at the end of their ropes. They can't get financing from banks. And they've run out of their own money. Every month the depression continues, more of these marginal businessmen must give up.

We have no statistics on this. Many of these small business people are not on the employment roles. They're entrepreneurs, not employees. So they don't get laid off...and don't get counted in the jobless figures; they never had jobs in the first place.

The official jobless numbers tell us that 10% of the workforce is unemployed. But here at The Daily Reckoning mobile headquarters, we don't believe any statistic...unless we twisted it ourselves. Even then, we have our doubts. What seems likely is that the number of people counted as 'jobless' understates the number of people who are not earning money the way they used to. That's why tax receipts are down...and why so many states are going broke.

Likewise, the latest statistics on housing were mixed - one up, one down. And now comes news that the number of used houses sold in December was disappointing - down 7.6% from a year before. The Washington Post says a housing recovery could take a decade. They're optimists at the Post. Most likely, there will be no recovery to Bubble-Era levels in our lifetimes.

Of course, that is not what the President of the United States of America thinks. He believes a recovery is underway...and that he can now take action to reduce the feds' stimulus. He's announced a partial spending freeze. This spending freeze is not exactly glacial. It's more like a spending breeze. Over the next 10 years it's expected to trim $250 billion from federal spending. Yet, the budget deficit for this year alone is $1.35 trillion. The cuts are negligible, in other words.

Just as we expected. The feds can talk the talk. But they can't walk the walk. Instead, they stumble from one error to a bigger one. From inciting a credit riot in the private sector...they've moved on to instigating a credit revolution in the public sector. When it is finally over...many nations will be broke...and the dollar will be worth a fraction of what it is worth today. What else could possibly happen? Well, nothing that we can see now. But there are always surprises, aren't there?

Most economists think the recession is over. And more investors think there is a bull market on Wall Street, and they expect it to continue. They are all going to be surprised. We are in a depression. It will cause 2010 top stocks market to fall again...probably pushing below their lows of March '09, down to the final bottom.

How can we be so sure? Well, we're not sure of anything. It's just an educated guess. Markets tend to oscillate between fear and greed over long periods of time. In the greed stage, credit generally expands. In the fear stage, it contracts. Obviously, there's a lot more to it than that. But people are -grosso modo - either optimistic and expansive or they are depressed and hunched over. When they are optimistic, asset prices rise...because they expect everything to get better. When they are depressed, asset prices fall...because they can't imagine that things will ever get better.

That's why August 1982 was such a great opportunity. BusinessWeek announced that the outlook for top stocks to buy was so bad it was the "Death of Equities." Death is about as bad as it gets. It couldn't get worse. So, it got better - a lot better, with stocks up 11 times over the next 20 years.

Then at the end of the '90s, a similar announcement was made about gold. We can't remember the source; perhaps it was Newsweek Magazine that pronounced gold 'dead' as an asset class. Then, what do you know? Gold rose from the dead and outperformed top stocks by five to one.

What's dead now? Hmmm... More below...

--- Outstanding Investments Gold Report ---

From Hulbert's No 1-Ranked Advisory Letter Over 5 Years, Our Most Shocking Forecast Yet...

GOLD $2,000

"I'm so sure gold will soar higher I'll even make you a guarantee... plus, I'll give you five entirely new ways to play the trend..."

"Including one hidden way to snap up gold... for less than one penny per ounce..."

How can that be possible?

And now, more thoughts...

What's so dead it's beginning to stink? The only thing we can think of is Japanese stocks. Every time we mention them, dear readers write to ask if we've lost our mind. The Japanese are growing old. They are up against not just a retirement crisis; they face extinction. They are not just figuratively dead...but literally dead. The government is headed toward monster debts...with no way to finance them. Already, they borrow more than a dollar for every dollar of tax receipts. Besides, the Chinese work cheaper. And the Chinese have the same technology...and the same access to capital...and a much bigger market.

As if to prove that Japan is dead, Toyota seems to have fouled up its accelerator mechanism. According to press reports, some Toyota automobiles go faster and faster even when you tell them not to. Drivers do not like that kind of insubordination. Only vulture lawyers do. So Toyota has had to shut down its assembly lines in order to mitigate the damages. So investors took a whack at Toyota shares yesterday; they fell 9%.

Is it the end of the road for Toyota...and for Japan?

Probably not. But we wait to see what happens...just like everyone else.

Gain From 2010 Top Stocks, How?

President Obama signed an Executive Order on Mon., March 9.

This Order lifted the ban on federal funding for key research. It was a watershed moment for science in America.

Why? Because the research avenues he opened with one swoop of his pen could not only someday save your life, but could also make you staggeringly rich. Fast.

In fact, here's part of what Obama said: "Medical miracles do not happen simply by accident. They result from painstaking and costly research — from years of lonely trial and error, much of which never bears fruit — and from a government willing to support that work."

What Obama didn't say however was that there are a select few companies who've already gone through much of the "trial and error."

These companies stand to do incredibly well in the near term — and Breakthrough Technology Alert editor Patrick Cox told his readers about them nearly eight months ago.

What you're about to read is your chance at what Patrick calls "three generations of wealth" — which could be yours as the bull market of the next decade heats up…

The most massive wealth creation in human history received a huge boost on Monday, March 9, 2009. To take part, you must act fast...

...really fast. Because I can only allow 558 406 lucky readers in on this historic opportunity...

Hanging in the balance — potentially millions of dollars for your family's next three generations.

Your children and grand-children can't afford for you to miss this report...

The major announcement from the White House on the morning of Monday, March 9, 2009 just tipped the scales in your favor.

By that I mean — what you're about to read will become the most important investing story of our lifetimes.

And I called it — months ago. I've done the research. I've interviewed all the key players...and I'm ready to tell you everything.

And the readers savvy enough to have acted on my initial recommendation in these companies are up as much as 208%. Don't worry — you can still act in time to make your own life-changing gains.

But only if you're one of the first 558 406 folks to respond to this urgent memo.

I'll explain that urgent limit in one moment. For now, back to the story:

It starts with one man...

He isn't a politician.

And he's not a Washington insider.

He's a scientist.

The man I'll introduce to you is one of several top scientists who have President Obama's ear on what could be the most critical market story of the next decade.

The ideas he controls are powerful enough to start a stream of wealth that could last your family three generations, or more.

What I'm about to share with you is the most important story you'll learn about all year.

I'm talking about the chance at millions of dollars for you and your loved ones.

In just a moment, I'm going to tell you all about this brilliant scientist.

I'll tell you about the company he controls.

I'll show you why his company (and companies he used to work for) could be so important to your financial future.

And I'll outline step-by-step why Barack Obama should listen to him so carefully.

Because the man you're about to meet is on the cutting-edge of a field with the potential to grow America out of our current economic mess.

Better yet, you could make huge profits from him regardless of your political beliefs.

What I'm about to share is "beyond" politics. In fact, two influential Senators (one from each party), have pledged to support President Obama's world-changing science declaration that took place just this Monday, March 9, 2009. More on this in just a minute...

But first, know this: The scientist I'll introduce could change the way every single person on the planet lives.

For the better.

Get in early enough, and you'll have a chance to rack up a pile of wealth that could even last your family three generations or more.

Because the world stands to change a great deal during President Obama's first 100 days in office. In fact, things are changing before our eyes. Today. As I write.

Let me explain...

This Trillion-Dollar Market Is Turning Into a Free-For-All During Obama's First 100 Days — Play it Right, And You Could Get Rich

One scientist I'll tell you about leads an industry that could grow tremendously in Obama's first term. It could even take off like a rocket during his first 100 days.

So I'm not kidding when I say this could be the biggest market story of our lives.

I can predict that with confidence because this scientist has a stellar 20-year track record of success.

In fact, some people consider him the "father" of this industry.

And Barack Obama knows just how important his field is to the future of the country. 

How?

Let me paint you a picture. When I'm done, I'll tell you exactly how it could come to pass. In fact, some of what I'll show you has already taken place.

That's why, very soon, I'll ask you to act on this information right away.

Now here's your immense profit opportunity in a nutshell...

We Could Hit "Critical Mass" in a Very Short Time — as Your Opportunity For Three Generations of Everlasting Wealth Stares You in the Face

Health, medical, and scientific regulations stand to change dramatically under the new Obama administration — which began with his inauguration on Jan. 20, 2009.

Huge changes are anticipated at the Food and Drug Administration, the National Science Foundation, as well as the National Institutes of Health.

The doors have swung wide open... and the story will wait for no one. Check out these recent quotes...

Harold Varmus — Chairman of White House Council of Advisers on Science and Technology: "We view what happened with [key research] in the last administration is... failure to think carefully about how federal support of science and the use of scientific advice occurs."

Dr. Curt Civin — Founding Director of the Univ. of Maryland Center for Stem Cell Biology and Regenerative Medicine: "Now the silly restrictions are lifted."

Sen Claire McCaskill, D-Missouri: Obama's Exec Order of March 9, 2009 will — "Once again say to the rest of the world that we will be the beacon for cures and for hope."

Sen. Arlen Specter, R-Pennsylvania: Regarding his Senate legislation (also with Sen. Tom Harkin, D — Iowa): The legislation would protect Obama's reversal of Bush science policy "so that it does not ping-pong back and forth with each successive president."

Sen. Harkin: "For too long, political interference has delayed research that holds the promise for millions of Americans who suffer from a wide range of diseases."

This means some ideas will be fast-tracked.

Even better, on the fastest-track of all could be the work of the scientist I'll introduce to you. His work could make a small group of people like you very rich.

Here's what's about to happen...

During his Saturday, Dec. 20, 2008 Internet address, President-Elect Barack Obama said:

To hear those words, you might think Obama meant the last eight years have seen science pushed to the side.

Well, depending on how you look at it, you'd be right.

Consider...

Both the National Institutes of Health and the National Science Foundation have seen their budgets flat line in recent years.

Because not only has Obama surrounded himself with some of the most brilliant scientific minds in America — he's gone on record by saying science will be a priority for his administration. He said it again on the morning of Monday, March 9.

With massive, wide-reaching changes expected at the FDA, as well as the potential restoration of appropriate budgets for the NIH and National Science Foundation...the biggest market story of the next decade is upon us.

Throw in an Executive Order on Monday, March 9... renewed funding...government clout — I'm talking about the chance at what could be an epic profit wave.

I'll explain it all in just a moment.

But for now, know this: You could be on the verge of becoming very, very rich.

And not just bank account rich.

But three generations rich.

Here's the scoop...

One Man With the Potential to Give You Three Generations of Wealth

It started with a letter.

The scientist I want to introduce to you co-wrote a letter to Barack Obama in late November.

The letter urged Obama, in pointed, specific terms, to embrace research and federal funding for industries that need it — and to make a certain technology a priority.

The letter also urged Obama to take a stand — to make science a part of his political philosophy. 

The response from the scientific community has been overwhelming....

And what hangs in the balance?

The future. Our nation's future. YOUR future.

Specifically, the fact that America is getting older. Baby boomers are starting to retire in massive numbers.

And sadly, many medical problems that have been a part of life for generations still plague society.

But that's about to change...

...because we're actually standing at the most lucrative and revolutionary moment in human history. Right now. Right here. Today. 

Because I'm about to reveal the industry that stands to benefit the most from President Obama's stated focus on science.

What you're about to read is "understood" by — at best — a few dozen people in the entire world.

Get in front of this story with the right companies for your portfolio, and you could become three generations rich. But only if you're one of the first 558 406 to respond to this historic invitation...

The rest of the world could begin to focus on this story in the coming days and weeks....

But you have a chance today to get in on the biggest story of the next decade...before everyone else.

Here are the details on the huge market story I'm so excited to write to you about...

"Get" These Simple Yet Revolutionary Ideas, And You Could Become Three Generations Rich

The single best way to sum up what I'm about to explain in detail is to simply say this:

The human body ALREADY holds the cure to every ailment ever known to mankind.

The thing is, the body is blocked from using these cures. The trick is to take out the "blocker" so the body can use its true power to crush any and all diseases.

Each human body is a universe of complexity. Somewhere inside all of us, deep in our network of tissues, nerves, neurons, and atoms rests the cure to all that could ever go wrong.

All we have to figure out is how to unlock these cures our bodies already hold. 

This same scientist hopes to give you a shot at three generations of huge wealth.

See, there are companies already on the major stock exchanges right here in the U.S. that are so close, it's staggering.

They're so close to curing so many different diseases.

In just a moment, I'll prove it to you.

You can see why this type of breakthrough could be the biggest story in the history of humankind.

I'm talking about an advance bigger than the spread of railroads in the 1860s. More lucrative than Henry Ford's mass-produced Model T car. And more revolutionary than the rise of computers.

All of those things helped people live, but the new advances I'm describing right now could actually GIVE PEOPLE LIFE.

That's why it promises to be the biggest breakthrough of all.

In fact, the blueprints are ready. Cures are in testing as I write to you today. The implications are unspeakably good for humankind...and unspeakably profitable.

And I've spent the last year interviewing everyone involved in these seismic shifts in knowledge.

The doctors, the researchers, the growth-minded CEOs, the venture capital investors — everyone.

Even the man who could help Obama usher in a new frontier of scientific funding, research and cures. What I've learned is this...

Imagine, In The Very Near  Future...

Imagine a sick person.

This person can have one of a hundred illnesses or diseases.

Now imagine the diagnosed person getting a few shots. Or taking a few pills.

The disease goes away.

The patient is free and clear.

Then, doctors give the patient a few more shots, and whatever organ or system in the body that was harmed by the disease repairs itself.

Just like new.

Better yet, after the disease disappears, the shots given to the patient could turn damaged organs or systems into those of a stout 20-year old person.

For example, let's take a retired gentleman who has a heart attack.

This man receives a series of shots that rebuild his heart — make it young again — giving him the heart and vascular tree of a healthy, vibrant 20-year old.

I know that sounds strange — but, then again, so did the railroad.

And so did the idea of mass-producing an affordable car — until the Model T rolled out of the factory.

And you know that no one thought almost every American home would have a small, personal computer in the 1980's...but it happened.

And people just like you became incredibly rich along the way.

What I'm describing could reverse cancer — wherever it may occur.

Then repair the afflicted organ or organs.

Imagine giving sight to the blind.

Memory and vitality back to those with Alzheimer's. Cures for Parkinson's...Type II Diabetes...the list is endless...

Just imagine the potential.

Now imagine everything I've just covered becoming a fast-tracked national research priority.

It's about to happen. In fact it's beginning, even in Obama's first 100 days in office. I must hear from you today if you want to take part in the staggering gains just around the corner... because the offer I'm about to make you is only open to the first 558 406 folks who respond.

But there's more...

The Potential To Make You Richer Than You Ever Imagined

Pills and shots. That's it. Simple. Safe. Painless. Quick. Revolutionary. Profitable.

And a way to cure, rebuild, and repair the human body.

The idea is no more revolutionary than if you had told a friend in 1862 that the railroad would someday criss-cross the country.

Or if someone in-the-know had pulled you aside in 1986 and told you Microsoft had the power to build its founder a $101 billion legacy of wealth by 1999.

That's how big these shots and pills could be. They could potentially cure nearly everything — and give you three generations of wealth...overnight.

Keep in mind, I'm not talking about "treatments". I'm talking about CURES.

I'm talking about giving 70-year olds the organs of people half their age — making 70 the new 40. And curing small children of horrible afflictions so they can get a fair shake at a full life.

Increasing healthy, vigorous, productive lifespan of the heart, maybe even by decades. In the blink of an eye.

Just imagine it. Imagine the implications. Imagine it all...

Everything I just described could be just around the corner. In fact, some of it is already here. In just a second, I'll give you all the details...

And one man stands behind many of these advances.

Starting with Day One of Obama's term, what I'm describing to you here could not only have science on its side — but government clout too.

Even if you don't believe me, consider the unavoidable investment possibility this field presents.

Before these cures land at a hospital near you, millions in profits could rest in the accounts of those who are in front of the story.

Actually, forget millions.

Billions Is More Like It...

In short, it's impossible to overstate the size of this world-changing shift that's underway.

It's impossible to put it in a nice little box and slap a dollar figure on its value.

What I'm going to explain to you could change the world.

It could change society.

It could change the face of human life itself.

And it could allow you to leave a staggering amount of money behind for future generations of your family.

In fact, you might still be around to enjoy your fortune with your future generations...

Because you could make so much money you wouldn't think twice about paying what it will cost at first to receive these cures.

The cost would be nothing compared to the value of a healthy, new heart and arteries...and nothing compared to the fortune you could control...

Imagine that...

Let me show you some more.

Dig deeper into the work of this incredible scientist. And explain to you why these miraculous advances are still so hush-hush.

Well, at least they were until today...

Your Three Generations of Wealth Began On Inauguration Day

The speed at which this emerging field is coming together is unprecedented.

That incredible speed keeps many people, including the press, way behind the cutting edge of these advances. And, sadly, there's a bit of ignorance and press skepticism too.

This is why you haven't heard about all of these breakthroughs until right now.

But all of this is set to change during Barack Obama's first days in office. Not too long after, you could be sitting on huge, life-changing profits. Fast.

Your fast-track to three generations of wealth could be that close.

Very shortly...those who are "in front of the story" could be millionaires. Or more... and if you're among the first 558 406 to respond to me today, you can put yourself in position to join them.

And everyone else who catches on will be stuck with the scraps. Because people like you could have already made the early money...the big money...the truly life-changing money.

In Five Minutes, You'll Make One of the Most Important Decisions You've Ever Made

To give you a chance to get in the real money as fast as possible, I want you to accept a report I've just finished called, Three Generations of Wealth From the Most Critical Market Story of Obama's Administration.

Inside, you'll learn the names of three companies.

The CEO from one of these companies is among several top scientists who have Obama's ear on several science and technology related issues. I'll tell you all about it in just a minute...

For now, there's this: All these companies trade on exchanges right here in the U.S.

Each one of these firms is working on a piece of the puzzle — and taken together, they could be the only three you need to grow incredibly wealthy.

Now here's the best part.

As I'm writing this letter to you — right now it's early 2009 — just $10.68 buys you a share in all three companies.

A measly $106.80 is ten shares of each.

And just $1,068 secures 100 shares of each.

What I'm saying is as little as $1,068 today could make you a millionaire. It could make your children, grandchildren and great-grandchildren millionaires.

$1,068's a tiny amount for a life-changing fortune that could start for you just a few days from today...

And that tiny amount is exactly why I must limit my offer to the first 558 406 respondents... you see, although these companies could change the world as we know it — and become something like the Microsoft's of tomorrow...

Right now they are tiny, relatively illiquid little companies. Any large amount of immediate attention might unduly affect their share prices. So we can't let any more than the first 558 406 people know about them...

Here's some hard proof why this is the most exciting time in history...

This Patent-Protected Advance is a Win-Win For You — But Only if You Act Right Now

The brilliant scientist who co-wrote the letter to Barack Obama controls key intellectual property directly related to the development of the shots I've been telling you about.

Each and every one of these patents could hold millions in value.

They could be the key to a lifetime of profits for his company, and for you.

This man's a shrewd businessman too. I estimate his intellectual property today to hold conservative value of over $200 million. In truth, it could be worth many, many times that amount.

How much did he pay to get it? A measly $1.2 million.

And he walked away with exclusive rights to his own research. He did it. He owns it. He controls it. It's his. The eventual profit explosions are going to go through him.

Because his new company could some day very soon turn even a small block of shares into a three generations long wealth legacy for you and your family.

Now here's how you can start seeing some of your life-changing profits perhaps as early as Obama's first 100 days in office...

With a likely greater focus on science in the new administration, I predict that the Food and Drug Administration — responsible for reviewing and approving new disease-fighting treatments — could fast-track certain technologies that have spent the last eight years on the back burner.

And in just a second, I'll show you how the companies in Three Generations of Wealth From the Most Critical Market Story of Obama's Administration stand ready to change the world if the doors at the FDA swing open.

The number of potential cures in the pipeline as I write is staggering. And one man is behind the technology that developed many of them. This man — the same brilliant researcher who sent the historic letter to Barack Obama — could make you incredibly rich.

While others will cast a wide net, and throw dollars at some companies with no chance of real, life-changing success, I'm going to give you the names of three companies that could make you as much as three generations of everlasting wealth.

That's why I need to hear from you today, so you can get your copy of Three Generations of Wealth From the Most Critical Market Story of Obama's Administration before we hit our forced limit of 558 406 new readers...

If you think that sounds like a profitable recipe — it gets better.

Imagine What Early Railroad or Computer Patents Were Worth...Then Multiply by 100

One company I'll tell you about in Three Generations of Wealth From the Most Critical Market Story of Obama's Administration recently had a major psoriasis treatment approved.

This company has 40 drugs currently in testing.

Eight are approaching Phase 3 approval.

This company is also working on revolutionary treatments for breast cancer, lung and kidney cancer...harnessing a "magic bullet" technology so revolutionary, I can't disclose how it works in these pages...

Plus...the brilliant scientist I've told you all about...well, the company he used to helm is up to some shockingly profitable work too.

In fact, they hold several key patents related to a new way of destroying cancer cells.

Along the way, they've also discovered what could be a true, a real — fountain of youth.

And they control the patents.

Licensing. Production. World-wide distribution.

The mountain of money just around the corner is staggering.

I can't give you all the details in this letter, even though I'd love to.

Just get your hands on my report in Three Generations of Wealth From the Most Critical Market Story of Obama's Administration and you'll have the FULL STORY right at your fingertips.

The ideas I'm sharing with you right now could make you unspeakably rich.

What I'm telling you are "in front of the story" ideas poised to make you generations of wealth — wealth like you've never imagined.

Because if these cures hit the market, a wave of new billionaires could pop up overnight.

The news could be crammed with stories about people who were regular Joes just like you and me who took an early stand on a big idea and became incredibly wealthy.

The safest, most protected and quickest way to get there is exactly the opportunity I'm offering you today.

Simply get Three Generations of Wealth From the Most Critical Market Story of Obama's Administration in your hands and you're ready to profit.

I'm not kidding when I say this is the most important letter you've ever read.

It could make you rich.

It could make the next three generations of your family wealthy.

It could give you a longer, fuller life. And you could live each day with the energy of a 20-year old.

And it all starts with the brilliant work of the CEO I've been telling you about.

Obama's pro-science attitude and the changes that may bring means this famous scientist could be about to become the hottest commodity in a rapidly growing field.

His work could change the world — and fuel a new future...one filled with promise...and profits, for people just like you and me.

This man has the know-how, the connections, and the track record of success to return to you three generations of enormous wealth...

Here's why...

When the Markets Put a Price Tag on Life — It Could Make You Three Generations Rich

The technologies to cure some diseases already work in tests.

The science behind one of these advances is Nobel Prize solid. All that remains before these cures come to market is to "work out some math".

But, as I said, the speed at which this advance is moving means tiny steps forward are compounding on top of each other. Progress is building...fast.

For example, a basic high school chemistry lab can do some of the "science" behind the heart-rebuilding shots...right now.

That's how brilliant these researchers are. They found an answer that was so simple.

Not only is the cure itself a huge step forward, but it's simple to repeat.

And the companies I just told you about own rafts of critical patents, which means any other firms that want to do it, have to pay them an incredible premium.

Ring the bell on your personal cash register — because what I just described could give you millions for at least three generations of your family.

Big Pharma is salivating too. Pfizer recently jumped into this field with both feet.

It boils down to this: The margins on these cures could be astounding.

Only the very rich would be able to afford the cures at first. In time, prices will come down and the cures could be truly universal — available to all who need them.

But you want to see the earliest money. Like I said before, some parts of the process are so simple, they'll be easy and cheap to repeat. But the price would be huge at first.

See what I mean about billions rolling in overnight?

So once the market decides exactly what these cures are worth, you could be so rich, so early, you'd easily be able to afford these cures for yourself.

And by the time they're cheap, you'd be out skiing with your great-grandkids.

That's the power of the opportunity this brilliant scientist is putting on the table for you today.

Just how big could the market be?

The Most Potentially Lucrative Market in World History is Open To YOU...But Not For Long

30% of all worldwide deaths are because of heart attacks, or a heart related ailment.

These cures could give 70-year olds strong, healthy, robust, young hearts.

I'm talking about making 70 the new 40. Making 100-year olds playing tennis with strong and healthy hearts a common thing.

How much is that worth?

If you were valuing the advance that made it all possible, what price tag would you stick on it?

Remember, analysts today are "conservatively" valuing this giant step forward at $1 trillion...and that's just over the next few years.

How much would you pay to get the names of the companies that do all this amazing work...before anyone else knew about them?

Before the story broke wide open in the press?

All you have to do is agree to receive Three Generations of Wealth From the Most Critical Market Story of Obama's Administration and you could be on your way to raking in legacy-style money on the biggest wealth creation in the history of the world.

But you must be among the first 558 406 readers to respond to this note. The companies I write about are small — they sometimes trade very few shares.

And the press I'm expecting in the coming days could soon drive the price way up — and a chance to see the best profits, you absolutely cannot delay.

This means you're going to have to act fast.

Speaking of fast, I know I've thrown a ton of info your way in just a few short pages.

So let me slow down for a minute and tell you all about myself.

Then, I promise I'll get right back to the simple step you need to take so you could become incredibly wealthy.

I've Built My Career On Being "In Front of The Story" — Many, Many Times Over

My name is Patrick Cox. I'm Editor of a research service called Breakthrough Technology Alert.

Maybe you've seen me on ABC's Nightline or CNN's Crossfire. Or maybe you've read my articles in The Wall Street Journal, or The Los Angeles Times.

I'm one of the most quoted and sought-after technology writers in America.

For example, I've written over 200 editorials for USA Today.

Now, I'm not trying to brag. In fact, besides writing about "in front of the story" ideas for over 25 years, I've also been in on the ground floor of quite a few.

My results? Well...you be the judge.

As publisher and editor of PC-SIG Magazine I wrote about topics like open-source and user-supported software, in 1987.

Most people outside the industry didn't even know what "software" was at the time.

Today, Microsoft alone makes $78 billion per year selling software. The industry overall sells hundreds of billions each year.

Later, I wrote presentations and speeches for the CEO of Netscape in the mid-1990s.

This was when Netscape was revolutionizing what it meant to "search the web".

And in 2000 and 2001, I wrote for an early example of what we now call "blogs".

This was for a site called Tom's Hardware Guide — the second-most visited PC hardware review site. In just the last seven years, blogging has become it's own billion dollar industry.

By the time I left, my section of Tom's Hardware Guide had over one million visitors every day.

I helped increase annual revenues for the site by 500% — more than doubling traffic during my time there.

I've also consulted for countless other companies through the years — on topics ranging from Technology Development to Public Relations and Governmental Affairs.

I've seen a lot of money change hands. I've met many interesting people.

Why I Can Only Tell 558 406 People About This Historic Opportunity...

The researcher I want to tell you all about in Three Generations of Wealth From The Most Critical Market Story of Obama's Administration leads a company so small, so revolutionary — I can almost promise you've never heard of it. As of today, it still trades relatively few shares each day.

But this same company is on to what could be the most shocking medical advance of our lifetimes — one that stands to make you three generations rich.

If just anyone could get their hands on the best stock to buy, the price might go up artificially. I absolutely cannot allow that to happen. My research has shown me that this company is too important to share with a wide audience.

Only the most serious, diligent and insightful readers can handle opportunities as small and fast moving as what I'm about to share with you.

That's exactly what I'm writing to you today.

And I've made a nice living by being inside these growing trends of wealth creation.

What I'm telling you today is bigger than anything I've ever written about. In fact, I'm staking my reputation on the fact that I'm right about this.

You could say that by writing you this letter today, I'm "coming out of hiding" with this shocking way for you to potentially provide generations of wealth for your family. No one else will tell you what I've already disclosed.

And you can get the full story just minutes from now when you accept Three Generations of Wealth From the Most Critical Market Story of Obama's Administration and put your self in position for what could be three lifetimes of gains.

Because recently, I decided to put my reputation on the line and start conducting extensive interviews with some of the men behind the companies I'm describing today — including the scientist who sent the gutsy, revolutionary letter to Obama himself.

These are companies with the knowledge to potentially cure disease and rebuild organs — companies that could easily help make 70 the new 40. Companies that could make you rich.

What these doctors and researchers had to say just bowled me over at first.

The profit potential for some of the cures they're discussing is so immense, so shocking, that this step forward could easily provide you and your loved ones with three generations of endless wealth.

It's all right around the corner. Simply agree to receive Three Generations of Wealth From the Most Critical Market Story of Obama's Administration from me at the end of this letter, and you'll be ahead of 99.9% of the rest of the world as the next great wealth creation gets underway, starting as early as just a few days from today.

Now, I promised I'd get right back to explaining the hard science behind these cures, so let's go one step further with our conversation, and imagine the broad market implications of this technology...

The First-Movers Have Already Lined Up To Get Legacy-Rich ...and You Can Join Them Right Now

With Three Generations of Wealth From the Most Critical Market Story of Obama's Administration you get all the upside life-changing profit potential, with little downside risk.

Not only could you begin to build a family fortune that will last for generations, you could also lead a new wave of global innovation...

Starting right now you can be a first-mover — put yourself squarely "in front of the story" — and be ready to profit. But only if you get in before 558 406 other lucky readers...

I've put in the years it takes to learn how to play breakthrough technology for maximum profits — and I've never seen anything like this.

In the pages of Breakthrough Technology Alert, for example, I recently alerted readers to a company that's up over 212% in a little over six months.

That's a great gain while the rest of the market is tanking.

But it's nothing compared to the gains that could materialize fast, starting as early as President Obama's first 100 days in office.

The profits I'm after in the pages of Three Generations of Wealth From the Most Critical Market Story of Obama's Administration are the profits that could make you "legacy" rich. These are truly disruptive, transformational profits that could build endless wealth.

But, like every other life-changing opportunity, this one's reserved only for the brave, innovative and lucky few.

I'm talking about the few willing to take a chance on an impressive vision — to stand apart from the crowds — and make life-changing profits on this groundbreaking idea.

I want to get this report in your hands as fast as possible, so you can pick up your shares if you choose to get in on the action — remember 100 shares of each as I write to you today is only $1,068 — and start your own three-generations long wealth legacy.

Before I show you how easy it is though...there's one more thing I need to cover...

Not Only Could You Be Rich, You Could Also Take Part in a New World

The cures I'm writing about to you today could come to market and change the world whether you act on what I've told you or not.

So if you're at all unsure as to whether or not this is the "real thing" — go ahead and ignore everything I've said so far.

But before you go — imagine this...

Imagine the world around you changing so much, and so fast...that you have to explain to your family how you could have been a part of it. How you could have made millions — not only for yourself but for future generations of your family too.

You want to have to tell that story?

I didn't think so. You need your copy of Three Generations of Wealth From the Most Critical Market Story of Obama's Administration and you need it today.

Curing all kinds of sicknesses and rebuilding hearts, it's a big story, I know.

It might even seem preposterous.

Well, I'll say it one more time.

These advances are huge. And the money you could make is preposterous. Just like how the innovators I've shown are preposterously wealthy.

Here's another example of the kind of giant leap forward I'm describing...

On Sept. 12, 1962, President John F. Kennedy famously said,

"But if I were to say, my fellow citizens, that we shall send to the moon, 240,000 miles away from the control station in Houston, a giant rocket more than 300 feet tall, the length of this football field, made of new metal alloys, some of which have not yet been invented, capable of standing heat and stresses several times more than have ever been experienced, fitted together with a precision better than the finest watch..."

Placing a man on the moon required unheard of technology. And Kennedy wanted to do it before the 1960s were over.

How many people thought it was a crazy idea that'd never happen?

But, as you and I know, on July 20, 1969 — Neil Armstrong took those famous first steps on the surface of the moon.

My point is this: I'm offering you a chance to grab your family's piece of a new world.

The chance to profit from the biggest breakthroughs in the history of mankind.

The chance to be around long enough to live a fuller, wealthier life.

Now imagine being incredibly rich on top of everything else I just described.

This IS the most important letter you've ever read.

And your journey to three generations of lasting, family wealth begins as soon as you agree to receive your urgent, limited copy of Three Generations of Wealth From the Most Critical Market Story of Obama's Administration.

I've said all I can say.

I've covered the story as best I can in this quick letter to you today. All that's left is for you to act and start profiting. Here's how you do it...

"Three Generations of Wealth From the Most Critical Market Story of Obama's Administration" — In Your Hands In Five Minutes, 100% RISK-FREE

At the end of this letter, simply click on the link, and you'll be just minutes away from reading your copy of Three Generations of Wealth From the Most Critical Market Story of Obama's Administration.

With the tickers of the three companies I've been telling you about in your hands, you could be ready to grab your shares and start raking in the profits, as early as during Obama's first 100 days in office.

Then, you could be well on your way to building a three generations-wide legacy of wealth for your family...

You'll also start receiving monthly issues and weekly trading alerts from me — straight from my desk at Breakthrough Technology Alert headquarters.

Inside these issues and alerts, I tell you all the latest news about our model portfolio and give you the latest scoop on the top stocks for 2010 we're tracking.

But that's not all you get. Here's the full breakdown of what you receive...

Monthly Issues of Breakthrough Technology Alert — Each month, you'll receive a profit-packed issue from me, guaranteed to have at least one new pick.
 
Weekly AND "FLASH" Email Alerts Directly From Me — If one of our positions changes or news breaks about one of our recommendations, I tell you everything I know. In short, I'll always keep you "in front of the story" with every pick I make. You get one email update each week, guaranteed. PLUS exclusive round-the-clock "FLASH" Alerts when you need to know something RIGHT AWAY.

Three Generations of Wealth From the Most Critical Market Story of Obama's Administration — sent right to your inbox, mere minutes after you join Breakthrough Technology Alert. You can read my full report on all three hot stocks for 2010, take a look at who I interviewed, and learn just how soon these cures could be hitting the open market and making you three generations rich. Remember, to have the best chance at the biggest early profits, you need to have this report in your hands today.

FIRST–READ Status For All Future Reports — Any special report I ever issue at any time in the future, you get a first look, before anyone else in the world has a chance to read it. Now that's some "in front of the story" profit potential.

FULL Breakthrough Technology Alert Website Access — As soon as you sign up, you'll receive a unique and exclusive Username and Password for the private Breakthrough Technology Alert website. You can look at all my past issues and alerts. You can track the model portfolio. You can read all my special reports.

FREE Membership to Penny Sleuth and The Agora Financial Executive Series — You'll also start receiving the most sought after and widely read e-letters in the world today. Penny Sleuth uncovers the best small-stock picks on the markets and shows you how to play "ignored" top stocks for the best profits. The Executive Series — comprised of the Rude Awakening and the 5 Min. Forecast, each give you a biting take on the day's market news and keep you "in the loop" with what's really happening on Wall Street.

After all this, you might be wondering what it costs to start receiving Breakthrough Technology Alert and get your hands on your copy of Three Generations of Wealth From the Most Critical Market Story of Obama's Administration.

The fact is, the profit-potential is so massive — these three companies and their cures are going to be so revolutionary — that I could easily charge $5,000 or more for you to get your hands on this report during the coming months.

$5,000 is nothing compared to what you could make overnight, especially after the global media attention that could take place for one of the three companies.

$5,000 for the chance to grab legacy-style riches is nothing. It's a drop in the bucket for the millions you could easily make — the millions you could pass on to future generations of your family.

But it doesn't take $5,000. Not today. Not for you.

It doesn't even take $2,500. Nowhere even near that, in fact...

Just $895 signs up you for Breakthrough Technology Alert and gets a copy of Three Generations of Wealth From the Most Critical Market Story of Obama's Administration in your hands.

Act today, and you get the report, the alerts, EVERYTHING — for just $895.

But you must be among the first 558 406 to respond...

...after 558 406 responses this offer could close forever.

See, right now you can get the report, read it, and read my monthly issues and weekly alerts — all 100% risk-free.

That's right. I'll even give you 60 full days to see if I'm right. Guaranteed. Even if you're sitting on huge profits in that time, just from the companies I want to tell you all about.

If I'm wrong and you're not happy with the opportunities I can bring you, you can cancel up to midnight on the 60th day of your subscription to Breakthrough Technology Alert and get your entire subscription price back. No questions asked.

But I'm sure you won't be canceling.

Not with the type of profits you could be seeing — the legacy-like wealth you could soon be raking in — not to mention the huge blanket of cash you could be in position to give future generations of your family.

It's risk-free. You can join Breakthrough Technology Alert and read Three Generations of Wealth From the Most Critical Market Story of Obama's Administration with no obligation whatsoever. But only if you are one of the first 558 406 readers who respond to this historic, discounted offer.

Even if you're No. 559, I must sadly turn you away. So there's absolutely no time to lose. No time to hesitate...

And put yourself in position to get rich as the revolutionary scientist who has Obama's ear leads the charge in the biggest market story of the next decade.

Here's to the amazing profits right around the corner with Breakthrough Technology Alert. I hope to hear from you today — because the profits could start at any time during Obama's first 100 days in office.